510(k) · Cleared
ClearedSapphire NC
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Orbusneich Medical, Inc. · LOX Catheters, Transluminal Coronary Angioplasty, Percutaneous
Cleared on Sep 1, 2011 as substantially equivalent to P790017 (Medtronic, Ireland, 1980) and 3 other predicates after a 246-day review. Its family tree reaches back 1 generation to 1980. 11 later devices descend from it.
- Decided
- Sep 1, 2011
- Review
- 246 days
- Class
- Class II
- Product code
- LOX
- Recalls
- None
- Predicates
- 4
Its longest line of descent runs back 1 generation to P790017 (1980). 4 ancestors in all. 11 later devices descend from it, 3 citing it directly.
- Root · 1 generation backP790017 Usci Dilatation CatheterMedtronic, Ireland · 1980
- This deviceK103808 Sapphire NCOrbusneich Medical, Inc. · 2011
- Descendant · cites it directly · 9 of its ownK162209 Sapphire NC PlusOrbusneich Medical, Inc. · 2016
- Descendant · cites it directly · 4 of its ownK163114 Sapphire II PROOrbusneich Medical, Inc. · 2017
- Descendant · 2 generations on · 3 of its ownK192344 Sapphire NC Plus Coronary Dilatation CatheterOrbusneich Medical Trading, Inc. · 2019
- Descendant · 2 generations on · 1 of its ownK211807 Sapphire NC 24OrbusNeich Medical (Shenzhen) Co., Ltd. · 2021
- Descendant · 2 generations on · 1 of its ownK173680 Sapphire II PROOrbusneich Medical Trading, Inc. · 2018
Showing 5 of 11 descendants. See all descendants
Descendants cleared per year
Most influential descendants
Showing 5 of 11 · See all- K162209Sapphire NC PlusOrbusneich Medical, Inc. · 2016 · cites it directly9descendants
- K163114Sapphire II PROOrbusneich Medical, Inc. · 2017 · cites it directly4descendants
- K192344Sapphire NC Plus Coronary Dilatation CatheterOrbusneich Medical Trading, Inc. · 2019 · 2 generations on3descendants
- K211807Sapphire NC 24OrbusNeich Medical (Shenzhen) Co., Ltd. · 2021 · 2 generations on1descendant
- K173680Sapphire II PROOrbusneich Medical Trading, Inc. · 2018 · 2 generations on1descendant
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | P790017 | Usci Dilatation Catheter | Medtronic, Ireland | 1980 | — |
| 0 (this device) | K103808 | Sapphire NC | Orbusneich Medical, Inc. | 2011 | — |
| +1 | K162209 | Sapphire NC Plus | Orbusneich Medical, Inc. | 2016 | — |
| +1 | K163114 | Sapphire II PRO | Orbusneich Medical, Inc. | 2017 | — |
| +2 | K192344 | Sapphire NC Plus Coronary Dilatation Catheter | Orbusneich Medical Trading, Inc. | 2019 | — |
| +2 | K211807 | Sapphire NC 24 | OrbusNeich Medical (Shenzhen) Co., Ltd. | 2021 | — |
| +2 | K173680 | Sapphire II PRO | Orbusneich Medical Trading, Inc. | 2018 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1982 | 1 | 0 |
| 1986 | 1 | 0 |
| 1988 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2016 | 1 | 0 |
| 2017 | 1 | 0 |
| 2018 | 2 | 0 |
| 2019 | 1 | 0 |
| 2021 | 3 | 0 |
| 2023 | 1 | 0 |
| 2024 | 2 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in LOX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new LOX device
- #1 K254022 FLASH Flex™ Aorto-Ostial Angioplasty Systemscore 12.3 · 5 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (4)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | P790017 | Usci Dilatation Catheter The summary prints P790017, a PMA number, which our reading took as K790017. Corrected to the number the summary prints. | 1980 |
| * | P810046 | Simpson-Robert Coronary Balloon Dilatation Cathete The summary prints P810046, a PMA number, which our reading took as K810046. Corrected to the number the summary prints. | 1982 |
| * | P860019 | Scimed Ptca Dilatation Catheter The summary prints P860019, a PMA number, which our reading took as K860019. Corrected to the number the summary prints. | 1986 |
| * | P880003 | Cordis Ptca Dilatation Catheter The summary prints P880003, a PMA number, which our reading took as K880003. Corrected to the number the summary prints. | 1988 |
What descends from it? (11)
See all 113 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
How does its category compare?
All LOX devicesLOX Catheters, Transluminal Coronary Angioplasty, Percutaneous: FDA decisions, review times, recalls and adverse event reports over 20 years. 2011, this device’s year, is highlighted.
FDA decisions per year · LOX
4in 2024
2026 to Oct 25, outlined.
Median 510(k) review, days · LOX
241in 2024
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · LOX
4in 2019
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · LOX
1,890in 2025
MAUDE reports naming product code LOX, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 19 | — | 1 | 1,053 |
| 2008 | 22 | — | 80 | 1,063 |
| 2009 | 28 | — | 0 | 1,353 |
| 2010 | 32 | — | 0 | 1,392 |
| 2011 | 9 | 103 | 0 | 2,090 |
| 2012 | 10 | 120 | 0 | 2,092 |
| 2013 | 6 | 123 | 0 | 2,436 |
| 2014 | 6 | 166 | 0 | 2,316 |
| 2015 | 4 | 119 | 0 | 2,060 |
| 2016 | 9 | 116 | 0 | 2,578 |
| 2017 | 6 | 113 | 0 | 2,753 |
| 2018 | 7 | 80 | 0 | 2,225 |
| 2019 | 1 | — | 4 | 2,102 |
| 2020 | 1 | — | 0 | 1,974 |
| 2021 | 6 | 167 | 0 | 1,738 |
| 2022 | 5 | 121 | 0 | 1,816 |
| 2023 | 4 | 138 | 0 | 1,720 |
| 2024 | 4 | 241 | 0 | 1,804 |
| 2025 | 0 | — | 0 | 1,890 |
| 2026 | 6 | 156 | 0 | — |
What is it indicated for?
The Sapphire NC Coronary Dilatation Catheter is indicated for:
* balloon dilatation of the stenotic portion of a coronary artery or bypass graft stenosis in patients evidencing coronary ischemnia for the purpose of improving myocardial perfusion
* balloon dilatation of a coronary artery occlusion for the treatment of acute myocardial infarction
* in-stent restenosis
* post-delivery expansion of balloon expandable coronary stents
Note: The subject device was tested on the bench with the OrbusNeich Blazer Cobalt-Chromium (CoCr) Alloy Stent. All stents should be deployed in accordance with the manufacturer's indications and instructions for use.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K103808 · printed Nov 6, 2026
Cite this page
510(k) Report. “K103808: Sapphire NC.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K103808
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026